http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102002476-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97651de1ceeb2411cad2574055776c20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
filingDate 2010-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0da669d7ae1e01f10de4615eb02ef5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7de20f85f484c832c5d0302f63e1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfa4748651655606f991fbbe84162146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a83eca9b2778a985578abdb6eec3921
publicationDate 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102002476-B
titleOfInvention Human mucous membrane living tissue model cultured in vitro as well as building method and application thereof
abstract The invention relates to an in vitro infection model of infection diseases, in particular to an infection model used in sexual transmitted disease prevention and mucous membrane immunization and a building method thereof, more specifically relates to a human mucous membrane living tissue model cultured in vitro as well as a building method and application thereof, which belong to the technical field of biomedicine. The human mucous membrane living tissue model cultured in vitro is provided by preprocessing an in vitro tissue sample, adopting different tissue culture modes, observing the form variation of the tissue cultured for different days, detecting tissue viability, evaluating the sensitivity of the tissue to medicine concentration variation and adopting a pseudovirus infection mucous membrane tissue. The model is suitable for the in vitro infection of in vitro human living tissues, and is cultured in vitro for a long term to discover strong viability. The model reproduces the real trajectory of HIV (Human immunodeficiency virus)-1 infecting human target cells, and provides a technical platform for the research on HIV-1 mucous membrane infection mechanism and the evaluation research on the safety and effectiveness of a novel biologic prevention technology before clinic application. The method can be developed in biosafety secondary laboratories.
priorityDate 2010-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11723
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11723
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710

Total number of triples: 30.